Related Experiment Videos

Clinical management of short children with low serum immunoglobulin but no immunodeficiency features

Cristina Meazza1, Paola Cerutti, Sara Pagani

  • 1Pediatric Department, University of Pavia, Research Laboratory, Pediatric Oncohematology, IRCCS San Matteo Foundation, Pavia, Italy.

Pediatrics International : Official Journal of the Japan Pediatric Society
|March 6, 2010
PubMed

Insights

Low immunoglobulin (Ig) levels in children failing to thrive may resolve over time. Monitoring these children is crucial to rule out immunodeficiency and ensure timely intervention for persistent hypogammaglobulinemia.

Area of Science:

  • Pediatric Immunology
  • Clinical Chemistry

Background:

  • Diminished immunoglobulin (Ig) levels are observed in children investigated for failure to thrive, often without overt signs of humoral immunodeficiency.
  • Further characterization of infants with low Ig levels is needed.

Purpose of the Study:

  • To investigate IgG subclasses, in vitro Ig production, and B cell subpopulations in children with low Ig levels.
  • To characterize infants presenting with diminished immunoglobulin levels.

Main Methods:

  • Studied 17 children (12 boys, 5 girls; age 1-18 years) with low serum Ig levels but no clinical or laboratory evidence of immunodeficiency.
  • Assessed IgG subclasses, in vitro Ig production, and B cell subpopulations.

Main Results:

  • Low IgM levels were frequent (52.9%).
  • Immunoglobulin levels normalized in 6 of 17 children (35.3%) during follow-up.
  • In vitro Ig production and B lymphocyte subpopulations were normal in all patients.

Conclusions:

  • Quantifying serum Ig levels in children failing to thrive can identify those with low Ig.
  • Monitoring children with low Ig levels is recommended to exclude immunodeficiency.
  • Early recognition of persistent hypogammaglobulinemia enables prompt clinical intervention.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...